Guidelines for the diagnosis and management




НазваниеGuidelines for the diagnosis and management
страница13/13
Дата07.09.2012
Размер6.48 Mb.
ТипДокументы
1   ...   5   6   7   8   9   10   11   12   13
2008;358:615–624.

144. Hennerici M, Klemm C, Rautenberg W. The subclavian steal phenomenon: a

common vascular disorder with rare neurologic deficits. Neurology 1988;38:

669–673.

145. Thijs RD, Kruit MC, van Buchem MA, Ferrari MD, Launer LJ, van Dijk JG.

Syncope in migraine: the population-based CAMERA study. Neurology 2006;66:

1034–1037.

146. Lempert T, Bauer M, Schmidt D. Syncope: a videometric analysis of 56 episodes

of transient cerebral hypoxia. Ann Neurol 1994;36:233–237.

147. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M. Diagnostic

criteria for vasovagal syncope based on a quantitative history. Eur Heart J

2006;27:344–350.

148. Parry SW, Kenny RA. Drop attacks in older adults: systematic assessment has a

high diagnostic yield. J Am Geriatr Soc 2005;53:74–78.

149. Abubakr A, Wambacq I. The diagnostic value of EEGs in patients with syncope.

Epilepsy Behav 2005;6:433–434.

150. Di Girolamo E, Di Iorio C, Leonzio L, Sabatini P, Barsotti A. Usefulness of a tilt

training program for the prevention of refractory neurocardiogenic syncope in

adolescents: a controlled study. Circulation 1999;100:1798–1801.

151. Reybrouck T, Heidbuchel H, Van De Werf F, Ector H. Long-term follow-up

results of tilt training therapy in patients with recurrent neurocardiogenic

syncope. Pacing Clin Electrophysiol 2002;25:1441–1446.

152. Foglia-Manzillo G, Giada F, Gaggioli G, Bartoletti A, Lolli G, Dinelli M, Del

Rosso A, Santarone M, Raviele A, Brignole M. Efficacy of tilt training in the treatment

of neurally mediated syncope. A randomized study. Europace 2004;6:

199–204.

153. Kinay O, Yazici M, Nazli C, Acar G, Gedikli O, Altinbas A, Kahraman H,

Dogan A, Ozaydin M, Tuzun N, Ergene O. Tilt training for recurrent neurocardiogenic

syncope: effectiveness, patient compliance, and scheduling the frequency

of training sessions. Jpn Heart J 2004;45:833–843.

154. On YK, Park J, Huh J, Kim JS. Is home orthostatic self-training effective in preventing

neurocardiogenic syncope? A prospective and randomized study.

Pacing Clin Electrophysiol 2007;30:638–643.

155. Duygu H, Zoghi M, Turk U, Akyuz S, Ozerkan F, Akilli A, Erturk U, Onder R,

Akin M. The role of tilt training in preventing recurrent syncope in patients

with vasovagal syncope: a prospective and randomized study. Pacing Clin Electrophysiol

2008;31:592–596.

156. Kaufman H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a

double-blind randomized cross-over study. Ann Neurol 2002;52:342–345.

157. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A. Effect of

etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a

double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope

International Study. Circulation 1999;99:1452–1457.

158. Samniah N, Sakaguchi S, Lurie KG, Iskos D, Benditt DG. Efficacy and safety of

midodrine hydrochloride in patients with refractory vasovagal syncope. Am J

Cardiol 2001;88:80–83.

159. Perez-Lugones A, Schweikert R, Pavia S, Sra J, Akhtar M, Jaeger F, Tomassoni GF,

SalibaW, Leonelli FM, Bash D, Beheiry S, Shewchik J, Tchou PJ, Natale A. Usefulness

of midodrine in patients with severely symptomatic neurocardiogenic

syncope: a randomized control study. J Cardiovasc Electrophysiol 2001;12:

935–938.

160. Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of

neurocardiogenic syncope. Heart 1998;79:45–49.

161. Qingyou Z, Junbao D, Chaoshu T. The efficacy of midodrine hydrochloride in

the treatment of children with vasovagal syncope. J Pediatr 2006;149:777–780.

162. Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing

syncope recurrence in children: a double blind, placebo-controlled, randomized

trial. J Am Coll Cardiol 2005:45;484–488.

163. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Effect of beta blockers on

the time to first syncope recurrence in patients after a positive isoproterenol tilt

table test. Am J Cardiol 1996;78:536–539.

164. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sa´nchez A, Pen˜a G,

Moro C. Lack of efficacy of atenolol for the prevention of neurally mediated

syncope in a highly symptomatic population: a prospective, double-blind, randomized

and placebo-controlled study. J Am Coll Cardiol 2001;37:554–559.

165. Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT.

Vasovagal syncope: a prospective, randomized, crossover evaluation of the

effect of propranolol, nadolol and placebo on syncope recurrence and patients’

well-being. J Am Coll Cardiol 2002;40:499–504.

166. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled

trial of acute and long-term medical therapy in tilt-induced neurally

mediated syncope. Am J Cardiol 1992;70:339–342.

167. Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M,

Ku T, Fouad-Tarazi F, Ritchie D, Koshman ML; POST Investigators. Prevention of

Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in

the prevention of vasovagal syncope. Circulation 2006;113:1164–1170.

168. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects

of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory

vasovagal syncope: a randomized, double-blind, placebo-controlled study.

J Am Coll Cardiol 1999;33:1227–1230.

169. Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A. Dualchamber

pacing in the treatment of neurally mediated tilt-positive cardioinhibitory

syncope: pacemaker versus no therapy: a multicenter randomized study.

The Vasovagal Syncope International Study (VASIS) Investigators. Circulation

2000;102:294–299.

170. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical

treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized,

controlled trial. Circulation 2001;104:52–57.

171. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal

Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for

the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16–20.

172. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL,

Morillo C, Gent M; VPS II Investigators. Pacemaker therapy for prevention of

syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal

Pacemaker Study (VPS II): a randomized trial. JAMA 2003;289:2224–2229.

173. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G, Sutton R,

Brignole M; Vasovagal Syncope and Pacing Trial Investigators. A randomized,

double-blind, placebo-controlled study of permanent cardiac pacing for the

treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope

and pacing trial (SYNPACE). Eur Heart J 2004;25:1741–1748.

174. Sud S, Massel D, Klein GJ, Leong-Sit P, Yee R, Skanes AC, Gula LJ, Krahn AD.

The expectation effect and cardiac pacing for refractory vasovagal syncope.

Am J Med 2007;120:54–62.

175. Sud S, Klein GJ, Skanes AC, Gula LJ, Yee R, Krahn AD. Implications of mechanism

of bradycardia on response to pacing in patients with unexplained syncope. Europace

2007;9:312–318.

176. Morley CA, Perrins EJ, Grant PL, Chan SL, Mc Brien DJ, Sutton R. Carotid sinus

syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular

sequential pacing. Br Heart J 1982;47:411–418.

177. Brignole M, Sartore B, Barra M, Menozzi C, Lolli G. Ventricular and dual

chamber pacing for treatment of carotid sinus syndrome. Pacing Clin Electrophysiol

1989;12:582–590.

178. Claydon VE, Hainsworth R. Salt supplementation improves orthostatic cerebral

and peripheral vascular control in patients with syncope. Hypertension 2004;43:

809–813.

179. Schroeder C, Bush VE, Norcliffe LJ, Luft FC, Tank J, Jordan J, Hainsworth R.

Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation

2002; 106:2806–2811.

180. van Lieshout JJ, ten Harkel AD, Wieling W. Physical manoeuvres for combating

orthostatic dizziness in autonomic failure. Lancet 1992;339:897–898.

181. Omboni S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W.

Mechanisms underlying the impairment in orthostatic tolerance after nocturnal

recumbency in patients with autonomic failure. Clin Sci (Lond) 2001;101:

609–618.

182. Smit AA, Wieling W, Fujimura J, Denq JC, Opfer-Gehrking TL, Akarriou M,

Karemaker JM, Low PA. Use of lower abdominal compression to combat orthostatic

hypotension in patients with autonomic dysfunction. Clin Auton Res 2004;

14:167–175.

183. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M,

Fouad-Tarazi FM. Neurogenic orthostatic hypotension: a double-blind, placebocontrolled

study with midodrine. Am J Med 1993;95:38–48.

184. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine

vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind

multicenter study. Midodrine Study Group. JAMA 1997;277:1046–1051.

185. Wright RA, Kaufman HC, Perera R, Opfer-Gehrking TL, McEllogott MA,

Sheng KN, Low PA. A double-blind, dose–response study of midodrine in neurogenic

orthostatic hypotension. Neurology 1998;51:120–124.

186. van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the

head-up position limit the postural decrease in CO in autonomic failure. Clin

Auton Res 2000;10:35–42.

187. Finke J, Sagemu¨ller I. Fludrocortisone in the treatment of orthostatic hypotension:

ophthalmodynamography during standing Dtsch Med Wochenschr 1975;

100:1790–1792.

188. ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension

with sleeping in the head-up tilt position, alone and in combination with fludrocortisones.

J Intern Med 1992;232:139–145.

189. Alboni P, Menozzi C, Brignole M, Paparella N, Gaggioli G, Lolli G, Cappato R.

Effects of permanent pacemaker and oral theophylline in sick sinus syndrome

the THEOPACE study: a randomized controlled trial. Circulation 1997;96:

260–266.

190. Sgarbossa EB, Pinski SL, Jaeger FJ, Trohman RG, Maloney JD. Incidence and predictors

of syncope in paced patients with sick sinus syndrome. Pacing Clin Electrophysiol

1992;15:2055–2060.

191. Pavlovic SU, Kocovic D, Djordjevic M, Belkic K, Kostic D, Velimirovic D. The

etiology of syncope in pacemaker patients. Pacing Clin Electrophysiol 1991;14:

2086–2091.

192. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN. Implantable defibrillator

event rates in patients with unexplained syncope and inducible sustained

ventricular tachyarrhythmias: a comparison with patients known to

have sustained ventricular tachycardia. J Am Coll Cardiol 1999;34:2023–2030.

193. Spirito P, Autore C, Rapezzi C, Bernabo` P, Badagliacca R, Maron MS,

Bongioanni S, Coccolo F, Estes NA, Barilla` CS, Biagini E, Quarta G,

Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic

cardiomyopathy. Circulation 2009;119:1703–1710.

194. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU,

Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G,

Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA 3rd, Buja G,

Thiene G. Implantable cardioverter-defibrillator therapy for prevention of

sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/

dysplasia. Circulation 2003;108:3084–3091.

195. Goldenberg J, Moss AJ. Long QT syndrome. J Am Coll Cardiol 2008;51:

2291–2300.

196. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Ge´rard F, Mabo P,

Reuter S, Lamaison D, Takahashi Y, O’Neill MD, Garrigue S, Pierre B, Jaı¨s P,

Pasquie´ JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P,

Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haı¨ssaguerre M,

Mansourati J, Cle´menty J, Le Marec H. Outcome after implantation of a

cardioverter-defibrillator in patients with Brugada syndrome: a multicenter

study. Circulation 2006;114:2317–2324.

197. Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I,

Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B;

Israeli Working Group on Cardiac Pacing and Electrophysiology. Outcome

after implantation of cardioverter defibrillator [corrected] in patients with

Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J

2008;10:435–439.

198. McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory,

and mixed carotid sinus syndrome in the elderly. Am J Med 1993;

95:203–208.

199. Galizia A, Abete P, Mussi C, Noro A, Morrione A, Langellotto A, Landi A,

Cacciatore F, Masotti G, Rengo F, Marchionni N, Ungar A. Role of the early

symptoms in assessment of syncope in the elderly people. Results from the

Italian Group for the Study of Syncope in the elderly (GIS STUDY). J Am

Geriatr Soc 2009;57:18–23.

200. Van der Velde N, van den Meiracker AH, Pols HA, Stricker BH, van der

Cammen TJ. Withdrawal of fall-risk-increasing drugs in older persons: effect

on tilt-table test outcomes. J Am Geriatr Soc 2007;55:734–739.

201. Shaw FE, Bond J, Richardson DA, Dawson P, Steen IN, McKeith IG, Kenny RA.

Multifactorial intervention after a fall in older people with cognitive impairment

and dementia presenting to the accident and emergency department: randomised

controlled trial. Br Med J 2003;326:73–80.

202. DiMario FJ. Prospective study of children with cyanotic and pallid breath-holding

spells. Pediatrics 2001;107:265–269.

203. Vlahos AP, Kolettis TM. Family history of children and adolescents with neurocardiogenic

syncope. Pediatr Cardiol 2008;29:227.

204. Vlahos AP, Tzoufi M, Katsouras CS, Barka T, Sionti I, Michalis LK,

Siamopoulou A, Kolettis TM. Provocation of neurocardiogenic syncope during

head-up tilt testing in children: comparison between isoproterenol and nitroglycerin.

Pediatrics 2007;119:e419–e425.

205. McLeod KA, Wilson N, Hewitt J, Norrie J, Stephenson JB. Cardiac pacing for

severe childhood neurally mediated syncope with reflex anoxic seizures. Heart

1999;82:721–725.

206. Maas R, Ventura R, Kretzschmar C, Aydin A, Schuchert A. Syncope, driving recommendations,

and clinical reality: survey of patients. Br Med J 2003;326:21.

207. Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C; Antiarrhythmics versus

Implantable Defibrillators Investigators. Resumption of driving after lifethreatening

ventricular tachyarrhythmia. N Engl J Med 2001;345:391–397.

208. Sorajja D, Nesbitt G, Hodge D, Low P, Hammill S, Gersh B, Shen WK. Syncope

while driving: clinical characteristics, causes, and prognosis. Circulation 2009,

doi:10.1161/CIRCULATIONAHA.108.827626.

209. Vijgen J, Botto G, Camm J, Hoijer C, Jung W, Le Heuzey J, Lubinski A,

Norekva°l TM, Santomauro M, Schalij M, Schmid J, Vardas P. Consensus

statement of the European Heart Rhythm Association: updated recommendations

for driving of patients with implantable cardioverter defibrillators. Europace

2009;11:1097–1107.

210. Huff JS, Decker WW, Quinn JV, Perron AD, Napoli AM, Peeters S, Jagoda AS;

American College of Emergency Physicians. Clinical policy: critical issues in

the evaluation and management of adult patients presenting to the emergency

department with syncope. Ann Emerg Med 2007;49:431–444.

211. Parry SW, Frearson R, Steen N, Newton JL, Tryambake P, Kenny RA. Evidencebased

algorithms and the management of falls and syncope in the acute medical

setting. Clinical Medicine 2008;8:157–162.

212. Petkar S, Cooper P, Fitzpatrick AP. How to avoid a misdiagnosis in patients

presenting with transient loss of consciousness. Postgrad Med J 2006;82:

630–641.

213. Shen WK, Decker WW, Smars PA, Goyal DG, Walker AE, Hodge DO,

Trusty JM, Brekke KM, Jahangir A, Brady PA, Munger TM, Gersh BJ,

Hammill SC, Frye RL. Syncope Evaluation in the Emergency Department

Study (SEEDS): a multidisciplinary approach to syncope management. Circulation

2004;110:3636–3645.

1   ...   5   6   7   8   9   10   11   12   13

Похожие:

Guidelines for the diagnosis and management iconGuidelines in classification, diagnosis, and treatment of the photodermatoses

Guidelines for the diagnosis and management iconGuidelines on the prevention, diagnosis
Руководящие принципы по профилактике, диагностике и лечению инфекционного эндокардита (новая версия 2009)
Guidelines for the diagnosis and management iconGuidelines on Management of Cancer Pain: Bibliography

Guidelines for the diagnosis and management iconEuropean guidelines for the management of chronic non-specific low back pain

Guidelines for the diagnosis and management iconGuidelines for curriculum development in records management and the administration of modern archives

Guidelines for the diagnosis and management iconGuidelines for the management of professional associations in the fields of archives, library and information work

Guidelines for the diagnosis and management iconUpdated general technical guidelines for the environmentally sound management of wastes consisting of, containing or contaminated with persistent organic pollutants (pops)

Guidelines for the diagnosis and management iconRiga teacher training and educational management academy management and economics department department of economics and entrepreneurship personnel Management

Guidelines for the diagnosis and management iconProject Management Methodology This list of suppliers was pre-qualified for the ict management Consultants multi-use list category of Project Management Methodology. Version 42. 0 – 31 July 2012

Guidelines for the diagnosis and management iconIn: advances in the diagnosis and treatment of alzheimer's disease

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница